Now showing items 1-1 of 1

    • Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP) 

      Ruiz-Patinõ, Alejandro; Arrieta, Oscar; Cardona-Mendoza, Andrés Felipe; Martín, Claudio Marcelo; Raez, Luis Estuardo; Zatarain-Barrón, Zyanya Lucia; Barron, Feliciano; Ricaurte, Luisa María; Bravo-Garzón, María A.; Mas, Luis A.; Corrales, Luis; Rojas Puentes, Leonardo; Lupinacci, Lorena; Perazzo, Florencia; Bas, Carlos Arturo; Carranza, Omar E.; Puparelli, Carmen; Rizzo, Miguel M; Ruiz, Rossana; Rolfo, Christian; Archila, Pilar; Rodríguez, July F.; Vargas Báez, Carlos Alberto; Carranza, Hernán; Otero, Jorge Miguel; Pino, Luis Eduardo; Ortíz, Carlos; Laguado, Paola; Rosell, Rafael Costa
      Background: To compare survival outcomes of patients with advanced or metastatic non-small cell lung cancer (NSCLC) who received immunotherapy as first-, second- or beyond line, versus matched patients receiving standard ...